REQUEST A DEMO
Total
USD $0.00
Search more companies

Ziboject S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ziboject S.A.S. Profile Updated: May 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ziboject S.A.S. is an enterprise based in Colombia. Its main office is in Bucaramanga. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on January 20, 2006. It currently has a total number of 26 (2024) employees. There was a net sales revenue increase of 11.94% reported in Ziboject S.A.S.’s latest financial highlights for 2023. Its total assets decreased by 1.03% over the same period. In, 2023, the company’s net profit margin increased by 5.27%.

Headquarters
Cr. 26 # 14-38 B. San Francisco
Bucaramanga; Santander;

Contact Details: Purchase the Ziboject S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Ziboject S.A.S. report to view the information.
Outstanding Shares:
Purchase the Ziboject S.A.S. report to view the information.
Incorporation Date:
January 20, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Ziboject S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.94%
Total operating revenue
13.04%
Operating profit (EBIT)
530.49%
EBITDA
421.39%
Net Profit (Loss) for the Period
2263.19%
Total assets
-1.03%
Total equity
23.42%
Operating Profit Margin (ROS)
7.47%
Net Profit Margin
5.27%
Return on Equity (ROE)
13.83%
Debt to Equity Ratio
-16.03%
Quick Ratio
0.32%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?